Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation

Stem Cells and Development

Volumn 23, Issue 11, 2014, Pages 1157-1167

  Viswanathan, Sowmya ^a   Keating, Armand ^a   Deans, Robert ^b   Hematti, Peiman ^c   Prockop, Darwin ^d   Stroncek, David F ^e   Stacey, Glyn ^f   Weiss, Dan J ^g   Mason, Christopher ^h   Rao, Mahendra S ⁱ  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b ATHERSYS INC   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^g UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADIPOSE DERIVED STEM CELL; ARTICLE; BONE MARROW; BONE MATRIX; CELL CULTURE; CRITICAL LIMB ISCHEMIA; FOOD AND DRUG ADMINISTRATION; GOLD STANDARD; GOOD CLINICAL PRACTICE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; MEDICAL RESEARCH; MESENCHYMAL STROMA CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT INDICATION; UMBILICAL CORD BLOOD; WORLD HEALTH ORGANIZATION; CONSENSUS; CULTURE TECHNIQUE; CYTOLOGY; HEALTH CARE FACILITY; MESENCHYMAL STEM CELL TRANSPLANTATION; PROCEDURES; STANDARD; STANDARDS; TRANSLATIONAL RESEARCH; TRENDS;

BIOLOGICAL SPECIMEN BANKS; BIOMEDICAL RESEARCH; CELL CULTURE TECHNIQUES; CONSENSUS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; REFERENCE STANDARDS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84901368359     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0591     Document Type: Article

References (31)

1. WHO. (2006). Recommendations for the preparation, characterization and establishment of international and other biological reference standards. WTR Series, ed. World Health Organization, Geneva.
2. Friedenstein AJ, RK Chailakhjan and KS Lalykina. (1970). The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393-403.
3. Caplan AI. (1991). Mesenchymal stem cells. J Orthop Res 9:641-650.
4. Phinney DG, G Kopen, RL Isaacson and DJ Prockop. (1999). Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J Cell Biochem 72:570-585.
5. Haniffa MA, MP Collin, CD Buckley and F Dazzi. (2009). Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica 94:258-263.
6. Hematti P. (2012). Mesenchymal stromal cells and fibroblasts: a case of mistaken identity? Cytotherapy 14:516-521.
7. Keating A. (2012). Mesenchymal stromal cells: new directions. Cell Stem Cell 10:709-716.
8. Phinney DG and L Sensebe. (2013). Mesenchymal stromal cells: misconceptions and evolving concepts. Cytotherapy 15:140-145.
9. Lock M, S McGorray, A Auricchio, E Ayuso, EJ Beecham, V Blouin-Tavel, F Bosch, M Bose, BJ Byrne, et al. (2010). Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material. Hum Gene Ther 21:1273-1285.
10. Muller FJ, BM Schuldt, R Williams, D Mason, G Altun, EP Papapetrou, S Danner, JE Goldmann, A Herbst, et al. (2011). A bioinformatic assay for pluripotency in human cells. Nat Methods 8:315-317.
11. Reading JL, JH Yang, S Sabbah, A Skowera, RR Knight, J Pinxteren, B Vaes, T Allsopp, AE Ting, et al. (2013). Clinicalgrade multipotent adult progenitor cells durably control pathogenic T cell responses in human models of transplantation and autoimmunity. J Immunol 190:4542-4552.
12. Roobrouck VD, C Clavel, SA Jacobs, F Ulloa-Montoya, S Crippa, A Sohni, SJ Roberts, FP Luyten, SW Van Gool, et al. (2011). Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions. Stem Cells 29:871-882.
13. Nishi H, T Nakada, S Kyo, M Inoue, JW Shay and K Isaka. (2004). Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT). Mol Cell Biol 24:6076-6083.
14. Larson BL, J Ylostalo, RH Lee, C Gregory and DJ Prockop. (2010). Sox11 is expressed in early progenitor human multipotent stromal cells and decreases with extensive expansion of the cells. Tissue Eng Part A 16:3385-3394.
15. Liu TM, WM Ng, HS Tan, D Vinitha, Z Yang, JB Fan, Y Zou, JH Hui, EH Lee and B Lim. (2013). Molecular basis of immortalization of human mesenchymal stem cells by combination of p53 knockdown and human telomerase reverse transcriptase overexpression. Stem Cells Dev 22:268-278.
16. Miljan EA, SJ Hines, P Pande, RL Corteling, C Hicks, V Zbarsky, M Umachandran, P Sowinski, S Richardson, et al. (2009). Implantation of c-mycER TAM immortalized human mesencephalic-derived clonal cell lines ameliorates behavior dysfunction in a rat model of Parkinson's disease. Stem Cells Dev 18:307-319.
17. Trivedi P and P Hematti. (2008). Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol 36:350-359.
18. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
19. Bourin P, BA Bunnell, L Casteilla, M Dominici, AJ Katz, KL March, H Redl, JP Rubin, K Yoshimura and JM Gimble. (2013). Stromal cells from the adipose tissuederived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 15:641-648.
20. Herlofsen SR, JC Bryne, T Hoiby, L Wang, R Issner, X Zhang, MJ Coyne, P Boyle, H Gu, et al. (2013). Genomewide map of quantified epigenetic changes during in vitro chondrogenic differentiation of primary human mesenchymal stem cells. BMC Genomics 14:105.
21. Krampera M, J Galipeau, Y Shi, K Tarte and L Sensebe. (2013). Immunological characterization of multipotent mesenchymal stromal cells-The International Society for Cellular Therapy (ISCT) working proposal. Cytotherapy 15:1054-1061.
22. Sacchetti B, A Funari, S Michienzi, S Di Cesare, S Piersanti, I Saggio, E Tagliafico, S Ferrari, PG Robey, M Riminucci and P Bianco. (2007). Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131:324-336.
23. Francois M, IB Copland, S Yuan, R Romieu-Mourez, EK Waller and J Galipeau. (2012). Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-gamma licensing. Cytotherapy 14:147-152.
24. Quirici N, D Soligo, P Bossolasco, F Servida, C Lumini and GL Deliliers. (2002). Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30:783-791.
25. Mendez-Ferrer S, TV Michurina, F Ferraro, AR Mazloom, BD Macarthur, SA Lira, DT Scadden, A Ma'ayan, GN Enikolopov and PS Frenette. (2010). Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466:829-834.
26. Cuthbert R, SA Boxall, HB Tan, PV Giannoudis, D McGonagle and E Jones. (2012). Single-platform quality control assay to quantify multipotential stromal cells in bone marrow aspirates prior to bulk manufacture or direct therapeutic use. Cytotherapy 14:431-440.
27. Gronthos S, SE Graves, S Ohta and PJ Simmons. (1994). The STRO-1 + fraction of adult human bone marrow contains the osteogenic precursors. Blood 84:4164-4173.
28. Meisel R, S Brockers, K Heseler, O Degistirici, H Bulle, C Woite, S Stuhlsatz, W Schwippert, M Jager, et al. (2011). Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2, 3-dioxygenase. Leukemia 25:648-654.
29. Meisel R, A Zibert, M Laryea, U Gobel, W Daubener and D Dilloo. (2004). Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2, 3-dioxygenase- mediated tryptophan degradation. Blood 103:4619-4621.
30. Ren G, J Su, X Zhao, L Zhang, J Zhang, AI Roberts, H Zhang, G Das and Y Shi. (2008). Apoptotic cells induce immunosuppression through dendritic cells: critical roles of IFN-gamma and nitric oxide. J Immunol 181:3277-3284.
31. Friedenstein A, UF Gorskaja and NN Kulagina. (1976). Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4:267-274.